Radiation-free AI technology, precision exercises, and lighter braces are adding options for patients and their families.

Fevold, consultant and CEO of Welker PR, is excited to share some of the changes happening at Mckenzie Health in Watford City ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has ...

Novo Nordisk A/S slumped after a pill from rival Eli Lilly & Co. helped patients shed weight and control blood sugar about as well as its injected blockbuster Ozempic. Bloomberg Intelligence ...